Literature DB >> 4683877

Interactions of the classical and alternate complement pathway with endotoxin lipopolysaccharide. Effect on platelets and blood coagulation.

M A Kane, J E May, M M Frank.   

Abstract

The contributions of the classical and alternate pathways of complement activation to the biological effects of endotoxin have been examined in the guinea pig, with particular reference to thrombocytopenia, leukopenia, and the development of the hypercoagulable state. Injection of endotoxin into normal guinea pigs led to a 95% fall in the level of circulating platelets within 15 min as well as a fall in circulating granulocytes. C4-deficient guinea pigs, known to have a complete block in the activity of the classical complement pathway, but with the alternate pathway intact, sustained no fall in platelets. The development of granulocytopenia proceeded normally. Endotoxin did activate the alternate complement pathway in C4D guinea pigs, as evidenced by the fall in C3-9 titers. With restoration of serum C4 levels, endotoxin-induced thrombocytopenia was observed in C4D animals. Thus, function of the classical complement pathway was an absolute requirement for the development of thrombocytopenia. Experiments performed in cobra venom factor (CVF)-treated normal guinea pigs, with normal levels of C1, C4, and C2, but with less than 1% of serum C3-9 demonstrated the importance of the late components in the development of thrombocytopenia but not leukopenia.C4-deficient guinea pigs had normal clotting times demonstrating that C4 was not required for normal clotting. In addition, development of the hypercoagulable state, evidenced by a marked shortening of the clotting time, was not observed on injection of endotoxin into C4D animals. Therefore, development of the hypercoagulable state paralleled the development of thrombocytopenia and required function of the classical complement pathway. Again, the importance of the late components of complement was emphasized by the failure of CVF-treated normal animals to develop hypercoagulability. These results demonstrate that endotoxin is capable of activating both the classical and alternate complement pathways in guinea pigs but that function of the classical pathway is an absolute requirement for the development of thrombocytopenia and the hypercoagulable state.

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4683877      PMCID: PMC302266          DOI: 10.1172/JCI107193

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  26 in total

1.  QUANTITATIVE STUDIES OF FEBRILE TOLERANCE AND LEVELS OF SPECIFIC ANTIBODY EVOKED BY BACTERIAL ENDOTOXIN.

Authors:  J H MULHOLLAND; S M WOLFF; A L JACKSON; M LANDY
Journal:  J Clin Invest       Date:  1965-06       Impact factor: 14.808

2.  Distribution and clearance of circulating endotoxin.

Authors:  W B HERRING; J C HERION; R I WALKER; J G PALMER
Journal:  J Clin Invest       Date:  1963-01       Impact factor: 14.808

3.  Properdin system and immunity. II. Interaction of the properdin system with polysaccharides.

Authors:  L PILLEMER; M D SCHOENBERG; L BLUM; L WURZ
Journal:  Science       Date:  1955-09-23       Impact factor: 47.728

4.  Immune adherence by the alternate complement pathway.

Authors:  J E May; M A Kane; M M Frank
Journal:  Proc Soc Exp Biol Med       Date:  1972-10

5.  The alternate complement pathway in cell damage: antibody-mediated cytolysis of erythrocytes and nucleated cells.

Authors:  J E May; I Green; M M Frank
Journal:  J Immunol       Date:  1972-09       Impact factor: 5.422

6.  Changes in the blood coagulation system associated with septicemia.

Authors:  J J Corrigan; W L Ray; N May
Journal:  N Engl J Med       Date:  1968-10-17       Impact factor: 91.245

7.  Platelet counts with the Coulter counter.

Authors:  B S Bull; M A Schneiderman; G Brecher
Journal:  Am J Clin Pathol       Date:  1965-12       Impact factor: 2.493

8.  The effects of bacterial endotoxin on rabbit platelets. V. Heat labile plasma factor requirements of endotoxin-induced platelet injury.

Authors:  R M Des Prez
Journal:  J Immunol       Date:  1967-11       Impact factor: 5.422

9.  An ultrastructural study of the mechanisms of platelet-endotoxin interaction.

Authors:  A R Spielvogel
Journal:  J Exp Med       Date:  1967-08-01       Impact factor: 14.307

10.  Effects of bacterial endotoxin on rabbit platelets. IV. The divalent ion requirements of endotoxin-induced and immunologically induced platelet injury.

Authors:  R M Des Prez; R E Bryant
Journal:  J Exp Med       Date:  1966-11-01       Impact factor: 14.307

View more
  13 in total

1.  The effect of anticomplementary substances on properdin in normal and C2-deficient sera.

Authors:  R H McLean; K Townsend; A F Michael
Journal:  Clin Exp Immunol       Date:  1975-03       Impact factor: 4.330

2.  Chronological changes in the complement system in sepsis.

Authors:  H Nakae; S Endo; K Inada; M Yoshida
Journal:  Surg Today       Date:  1996       Impact factor: 2.549

3.  [Relations between complement and blood coagulation (author's transl)].

Authors:  G Müller-Berghaus
Journal:  Klin Wochenschr       Date:  1977-07-15

Review 4.  The effects of bacterial endotoxins on host mediation systems. A review.

Authors:  D C Morrison; R J Ulevitch
Journal:  Am J Pathol       Date:  1978-11       Impact factor: 4.307

Review 5.  Interaction of platelets with bacterial endotoxins.

Authors:  N Semeraro; A Lattanzio
Journal:  Agents Actions       Date:  1983-08

6.  Complement-dependent accumulation and degradation of platelets in the lung and liver induced by injection of lipopolysaccharides.

Authors:  M Shibazaki; Y Kawabata; T Yokochi; A Nishida; H Takada; Y Endo
Journal:  Infect Immun       Date:  1999-10       Impact factor: 3.441

7.  Complement and meningococcal infection.

Authors:  B M Greenwood; I I Onyewotu; H C Whittle
Journal:  Br Med J       Date:  1976-04-03

8.  Thromboxane A2 biosynthesis during endotoxin-induced aggregation of platelets from normal and sensitized guinea-pigs.

Authors:  H Bult; A G Herman
Journal:  Agents Actions       Date:  1979-12

9.  Transient neutropenia after intravenous injection of vindesine in patients with lung cancer.

Authors:  K Aoshiba; A Nagai; H Ueno; K Konno
Journal:  Eur J Clin Pharmacol       Date:  1994       Impact factor: 2.953

10.  Potentiation of endotoxin-induced consumptive coagulopathy by lead acetate administration.

Authors:  R B Jones; L A Kiesow
Journal:  Infect Immun       Date:  1974-12       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.